The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the re-appointment of Mr. Vijay S Shanbhag as the Internal Auditor of the Company under Section ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
HCG's Board meeting on May 19, 2026 approved multiple leadership changes. Key appointments include Mr. Sanjeev Kumar as CFO and KMP (effective May 25), bringing 30+ years of experience from Bharti Airtel, InterGlobe Enterprises, and Medanta where he led the Global Health IPO. Mr. Rajiv Maliwal is re-appointed as Non-Executive Independent Director for a second 5-year term, also effective May 25, pending shareholder approval. Dr. Manish Mattoo, currently Executive Director & CEO serving as Interim CFO, will cease the CFO role as the new appointment takes over. Additionally, Mr. Ravi Gothwal joins as AVP – Investor Relations (Senior Management) effective immediately, and Mr. Vijay S. Shanbhag is re-appointed as Internal Auditor for one year from May 30, 2026.
The appointment of a permanent, experienced CFO after a period with an interim CFO indicates improved financial leadership stability. The re-appointment of a seasoned independent director and addition of dedicated investor relations management signals focus on governance and shareholder communication, which could be viewed positively by the market.